Back to search

Peptide record

TPDB26338

Antibacterial Anticancer Toxicity standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26338
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 9-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
VVRWWWRVV
Physicochemical Analysis
C65H92N18O10
ANDCEQGHILKMFPSTY
V
1285.56
12.40
2
0
7
+2
-3.65
0.567
128.89
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
16500
1283.49
0
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
0
F
0
P
0
S
0
T
3
W
0
Y
4
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 3 Y: 0 V: 4
Chemical Descriptors
9
C65H92N18O10
1285.56
12.40
+2
-3.65
0.567
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Novel Arginine End-Tagging Antimicrobial Peptides to Combat Multidrug-Resistant Bacteria | ACS Appl Mater Interfaces | 2022
Evidence 2 Activity

Activity

10% Killing
Toxicity
64 µM
Cytotoxic
10% Killing | 64 | µM | target cell: Vero cells

Target

Vero cells

Source & Reference

NA
DBAASP
Novel Arginine End-Tagging Antimicrobial Peptides to Combat Multidrug-Resistant Bacteria | ACS Appl Mater Interfaces | 2022